Diasome Pharmaceuticals' Debt Round

Diasome Pharmaceuticals raised a round of funding on January 17, 2017.

Diasome Pharmaceuticals is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fie…

Articles about Diasome Pharmaceuticals' Debt Round: